drugset / Trial / NCT03747497
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether contezolid acefosamil is as safe and effective as linezolid in the treatment of adult patients with acute bacterial skin and skin structure infections
Timeline
- Start
- 2018-11-15
- Primary completion
- 2019-03-26
- Completion
- 2019-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linezolid | Other / unclassified | 600 mg | Intravenous |
| Subject | contezolid acefosamil | Unknown | 1300 mg | Intravenous |